Research and Markets: Triptans (Migraine)

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/lwwcrv/triptans) has announced the addition of the “Triptans (Migraine) – Forecast and Market Analysis to 2023″ report to their offering. The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as …

Research and Markets: Beta Blockers (Migraine)

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/8f3cmx/beta_blockers) has announced the addition of the “Beta Blockers (Migraine) – Forecast and Market Analysis to 2023″ report to their offering. By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities …

Research and Markets: Levadex (Migraine)

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/6jlq2t/levadex) has announced the addition of the “Levadex (Migraine) – Forecast and Market Analysis to 2023″ report to their offering. The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as …

Research and Markets: Global Calcium Channel Antagonists (Migraine) Forecasts and Opportunities to 2023

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/7f5sxj/calcium_channel) has announced the addition of the “Calcium Channel Antagonists (Migraine) – Forecast and Market Analysis to 2023″ report to their offering. By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but …

Research and Markets: AVP

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/mc2bt6/avp825) has announced the addition of the “AVP-825 (Migraine) – Forecast and Market Analysis to 2023″ report to their offering. By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will …

  • DON’T  LEAVE  EMPTY-HANDED !!!

    Download your FREE Report on Headache

    slide12t

    Just a sneak peek…

    • Guide to cluster headache
    • Why do you get a headache?
    • Headache and migraine pain relief through hypnotherapy
    • Can stress cause severe headache?
    • Caffeine: the culprit behind our migraines
    • Menopause and headaches
    • Sinusitis: how serious is it?
    Download It Completely FREE

    Just Insert Your Name and email

    We will also send you a Complimentary copy of our Headache Newsletter. Our newsletter subscription has the latest information on Headache and Migraine treatments.

    We respect your privacy. We will NEVER sell, rent or share your email address. That’s more than a policy, it’s our personal guarantee!

  • Now you can have the Latest News on Headache

    hedac02-220

    Worried about Headache and Migraine? You can have now information about the latest treatments and medical research. All this and more in our Headache Newsletter.slide11t

    Try it for four weeks. We will even send you FREE our bonus health e-book with your trial subscription.

    All for just ONE PENNY

    Get the latest information – don’t be left in the dark on your condition.

     CLICK HERE 

    Check our special offer: Subscribe to one newsletter, get another newsletter for FREE!